NYSE:CC Chemours - CC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. $28.80 +0.42 (+1.48%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$27.75▼$28.8150-Day Range$28.38▼$36.7352-Week Range$23.58▼$44.95Volume625,284 shsAverage Volume1.10 million shsMarket Capitalization$4.29 billionP/E Ratio8.07Dividend Yield3.47%Price Target$36.33 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Chemours MarketRank™ ForecastAnalyst RatingHold2.20 Rating ScoreUpside/Downside26.2% Upside$36.33 Price TargetShort InterestBearish3.07% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews Sentiment0.57Based on 7 Articles This WeekInsider TradingSelling Shares$983,087 Sold Last QuarterProj. Earnings Growth23.21%From $3.92 to $4.83 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.18 out of 5 starsBasic Materials Sector6th out of 160 stocksChemicals & Allied Products Industry1st out of 15 stocks 4.1 Analyst's Opinion Consensus RatingChemours has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $36.33, Chemours has a forecasted upside of 26.2% from its current price of $28.80.Amount of Analyst CoverageChemours has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.07% of the float of Chemours has been sold short.Short Interest Ratio / Days to CoverChemours has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Chemours has recently increased by 7.69%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldChemours pays a meaningful dividend of 3.34%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthChemours does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Chemours is 28.01%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemours will have a dividend payout ratio of 20.70% next year. This indicates that Chemours will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CC. Previous Next 3.1 News and Social Media Coverage News SentimentChemours has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.30 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Chemours this week, compared to 5 articles on an average week.Search Interest21 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 11 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemours insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $983,087.00 in company stock.Percentage Held by InsidersOnly 1.63% of the stock of Chemours is held by insiders.Percentage Held by Institutions71.89% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Chemours are expected to grow by 23.21% in the coming year, from $3.92 to $4.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemours is 8.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.61.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemours is 8.07, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 82.59.Price to Earnings Growth RatioChemours has a PEG Ratio of 1.19. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemours has a P/B Ratio of 3.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Chemours (NYSE:CC) StockThe Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.Read More Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Email Address CC Stock News HeadlinesMarch 23, 2023 | finance.yahoo.comChemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance MaterialsMarch 23, 2023 | americanbankingnews.comThe Chemours Company (NYSE:CC) Receives $36.33 Average PT from BrokeragesMarch 24, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 20, 2023 | finance.yahoo.comHow Better Chemistry Catalyzes DecarbonizationMarch 19, 2023 | americanbankingnews.comChemours (NYSE:CC) Coverage Initiated by Analysts at StockNews.comMarch 16, 2023 | finance.yahoo.comChemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim LeaderMarch 15, 2023 | finance.yahoo.comHydrogen Central – Interview with Gerardo Familiar, Head of Chemours Hydrogen Economy VentureMarch 13, 2023 | finance.yahoo.comChemours Korea Named to 2023 Best Workplaces(TM) in Korea by Great Place to Work®March 24, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 1, 2023 | finance.yahoo.comChemours China Again Named to Best Workplaces in Greater China(TM) in 2022February 25, 2023 | finance.yahoo.comChemours (NYSE:CC) pulls back 3.8% this week, but still delivers shareholders solid 37% CAGR over 3 yearsFebruary 21, 2023 | finance.yahoo.comChemours: How Black History Can Shape the Future of STEMFebruary 21, 2023 | finance.yahoo.comChemours Announces the Winners of its 2022 Responsible Supplier AwardsFebruary 15, 2023 | finance.yahoo.comChemours Introduces Track & Trace Technology to Provide Real-Time Visibility into Ti-Pure™ TiO2 Order and Delivery StatusFebruary 14, 2023 | finance.yahoo.com‘Forever Chemicals’ Maker Defends Their Use, Says It Will Keep Producing ThemFebruary 13, 2023 | seekingalpha.comThe Chemours Company: Market Volatility May Present Buying OpportunityFebruary 13, 2023 | finance.yahoo.comChemours (CC) Posts Break-Even Q4 Earnings, Sales MissFebruary 11, 2023 | finance.yahoo.comChemours Full Year 2022 Earnings: Revenues In Line With ExpectationsFebruary 10, 2023 | seekingalpha.comChemours sees TiO2 market improving gradually through 2023February 10, 2023 | finance.yahoo.comChemours (CC) Q4 2022 Earnings Call TranscriptFebruary 10, 2023 | finance.yahoo.comChemours (CC) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesFebruary 10, 2023 | finance.yahoo.comChemours (NYSE:CC) Will Pay A Dividend Of $0.25February 9, 2023 | finance.yahoo.comThe Chemours Company Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 OutlookFebruary 9, 2023 | finance.yahoo.comUPDATE 2-Chemours forecasts better-than-expected earnings for 2023 on stronger demandFebruary 9, 2023 | finance.yahoo.comChemours (CC) Reports Break-Even Earnings for Q4February 9, 2023 | finance.yahoo.comCORRECTING and REPLACING Chemours Announces First Quarter DividendFebruary 7, 2023 | finance.yahoo.comChip suppliers warn on EU plan to bar ‘forever chemicals’See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Email Address CC Company Calendar Last Earnings11/04/2021Ex-Dividend for 3/15 Dividend2/23/2023Dividend Payable3/15/2023Today3/24/2023Next Earnings (Estimated)5/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:CC CUSIPN/A CIK1627223 Webwww.chemours.com Phone(302) 773-1000FaxN/AEmployees6,600Year FoundedN/APrice Target and Rating Average Stock Price Forecast$36.33 High Stock Price Forecast$43.00 Low Stock Price Forecast$27.00 Forecasted Upside/Downside+28.0%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$3.57 Trailing P/E Ratio7.95 Forward P/E Ratio7.24 P/E Growth1.16Net Income$578 million Net Margins8.51% Pretax Margin10.91% Return on Equity61.75% Return on Assets9.62% Debt Debt-to-Equity Ratio3.24 Current Ratio1.70 Quick Ratio0.96 Sales & Book Value Annual Sales$6.79 billion Price / Sales0.62 Cash Flow$6.71 per share Price / Cash Flow4.23 Book Value$7.34 per share Price / Book3.87Miscellaneous Outstanding Shares148,805,000Free Float146,379,000Market Cap$4.22 billion OptionableOptionable Beta1.88 Key ExecutivesMark E. NewmanPresident, Chief Executive Officer & DirectorSameer RalhanChief Financial Officer & Senior Vice PresidentKristine WellmanSecretary, Senior Vice President & General CounselCamela T. WiselChief Accounting Officer, VP & ControllerAlisha BellezzaPresident-Thermal & Specialized SolutionsKey CompetitorsBalchemNASDAQ:BCPCLiventNYSE:LTHMHuntsmanNYSE:HUNAshlandNYSE:ASHUnivar SolutionsNYSE:UNVRView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCSold 4,884 shares on 3/23/2023Ownership: 0.066%B. Riley Wealth Advisors Inc.Bought 6,590 shares on 3/15/2023Ownership: 0.004%Alisha BellezzaSold 27,716 sharesTotal: $983,086.52 ($35.47/share)Rockefeller Capital Management L.P.Bought 11,847 shares on 3/6/2023Ownership: 0.025%Robotti RobertSold 965 shares on 3/3/2023Ownership: 0.080%View All Insider TransactionsView All Institutional Transactions CC Stock - Frequently Asked Questions Should I buy or sell Chemours stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares. View CC analyst ratings or view top-rated stocks. What is Chemours' stock price forecast for 2023? 10 Wall Street research analysts have issued twelve-month target prices for Chemours' shares. Their CC share price forecasts range from $27.00 to $43.00. On average, they expect the company's stock price to reach $36.33 in the next year. This suggests a possible upside of 28.0% from the stock's current price. View analysts price targets for CC or view top-rated stocks among Wall Street analysts. How have CC shares performed in 2023? Chemours' stock was trading at $30.62 on January 1st, 2023. Since then, CC shares have decreased by 7.3% and is now trading at $28.38. View the best growth stocks for 2023 here. Are investors shorting Chemours? Chemours saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 4,480,000 shares, an increase of 7.7% from the February 13th total of 4,160,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 4.2 days. Currently, 3.1% of the shares of the company are short sold. View Chemours' Short Interest. When is Chemours' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023. View our CC earnings forecast. How were Chemours' earnings last quarter? The Chemours Company (NYSE:CC) posted its earnings results on Thursday, November, 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.28. The specialty chemicals company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.58 billion. Chemours had a trailing twelve-month return on equity of 61.75% and a net margin of 8.51%. The firm's revenue was up 36.3% compared to the same quarter last year. During the same period last year, the firm posted $0.47 earnings per share. How often does Chemours pay dividends? What is the dividend yield for Chemours? Chemours declared a quarterly dividend on Monday, February 6th. Shareholders of record on Friday, February 24th will be given a dividend of $0.25 per share on Wednesday, March 15th. This represents a $1.00 annualized dividend and a dividend yield of 3.52%. The ex-dividend date is Thursday, February 23rd. Read our dividend analysis for CC. What ETFs hold Chemours' stock? ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include ProShares Smart Materials ETF (TINT), First Trust Materials AlphaDEX Fund (FXZ), Alpha Architect U.S. Quantitative Value ETF (QVAL), BlackRock Future U.S. Themes ETF (BTHM), Invesco DWA Basic Materials Momentum ETF (PYZ), First Trust Dorsey Wright Momentum & Value ETF (DVLU), Invesco S&P MidCap Value with Momentum ETF (XMVM) and First Trust Dorsey Wright Momentum & Dividend ETF (DDIV). Is Chemours a good dividend stock? Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.34%. The dividend payout ratio is 28.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CC will have a dividend payout ratio of 20.70% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CC. What guidance has Chemours issued on next quarter's earnings? Chemours updated its FY23 earnings guidance on Thursday, February, 9th. The company provided EPS guidance of $3.80-4.29 for the period, compared to the consensus earnings per share estimate of $4.06. What is Mark Vergnano's approval rating as Chemours' CEO? 106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees. What other stocks do shareholders of Chemours own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET). What is Chemours' stock symbol? Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC." Who are Chemours' major shareholders? Chemours' stock is owned by many different retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.96%), JPMorgan Chase & Co. (1.91%), Dimensional Fund Advisors LP (1.55%), Geode Capital Management LLC (1.38%), AQR Capital Management LLC (1.13%) and Norges Bank (1.02%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott and Sameer Ralhan. View institutional ownership trends. How do I buy shares of Chemours? Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Chemours' stock price today? One share of CC stock can currently be purchased for approximately $28.38. How much money does Chemours make? Chemours (NYSE:CC) has a market capitalization of $4.22 billion and generates $6.79 billion in revenue each year. The specialty chemicals company earns $578 million in net income (profit) each year or $3.57 on an earnings per share basis. How many employees does Chemours have? The company employs 6,600 workers across the globe. How can I contact Chemours? Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com. This page (NYSE:CC) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.